Dr. Sandra Lynn Ettema, MD, PhD

Dr. Ettema practices at Sarah Bush Lincoln Health Center in Mattoon, Illinois, part of Sarah Bush Lincoln Health System.

Dr. Ettema's NPI, 1760577902, was assigned on October 4, 2006. Dr. Ettema graduated from University of Illinois College of Medicine - Chicago in 2002. Dr. Ettema holds Illinois license 036.118460.

Dr. Ettema's primary practice is Sarah Bush Lincoln Health Center, at 1000 Health Center Drive P O Box 372, Mattoon, IL 61938 in Coles County. The practice phone is (217) 258-2513.

Dr. Ettema's primary practice is Sarah Bush Lincoln Health Center in Mattoon, Illinois, part of Sarah Bush Lincoln Health System. Dr. Ettema is also affiliated with HSHS St. Anthony's Memorial Hospital. The medical group on file is Sarah Bush Lincoln. Dmand AI also links Dr. Ettema to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ettema practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Ettema's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Ettema is board certified in general otolaryngology by the American Board of Otolaryngology. Dmand AI has Dr. Ettema's licenses on file in 2 states: Illinois and Wisconsin.

Dmand AI lists chronic nasal allergies, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Ettema treats.

CMS data shows 431 Medicare services from Dr. Ettema across 9 procedure codes in 2024, for 162 Medicare patients. Medicare paid $31,989 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 162 Medicare patients who saw Dr. Ettema in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ettema's median patient age at 67, with 56% women.

In 2024, Dr. Ettema wrote 743 Medicare Part D claims for 206 patients. 97% of them were for generic drugs. CMS names the drug for 659 of them, across 11 drugs with 11 or more claims each, at $11,629 in total drug cost. In 2023, CMS named 743 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ettema for performance year 2024, reported through an alternative payment model (APM). Dr. Ettema accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ettema, more than 63% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Ettema, published from 2005 to 2021. 2011 was the busiest year, with 2. The most frequent topics are Laryngoscopy, Laryngostenosis and Magnetic Resonance Imaging. Dr. Ettema has published most often in Ann Otol Rhinol Laryngol. Dr. Ettema's most frequent co-authors are Dana Lynn Crosby, MD, Craig Elliot Berzofsky, MD and Stacie Renee Gregory, MD.

Dmand AI links Dr. Ettema to 1 clinical trial. Conditions studied include Lymphedema and Head and Neck Neoplasms.

CMS Open Payments shows 31 general payments to Dr. Ettema from 10 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 52% of the total. Acclarent, Inc paid the most, $1,475.

Dr. Ettema graduated from University of Illinois College of Medicine - Chicago in 2002.

Dr. Ettema is in network with 7 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.